Both in Biotechnology
CRISPR Therapeutics AG vs Adaptive Biotechnologies
Over the past year CRSP returned −19.6% and ADPT returned +53.5%; their daily moves had a correlation of 0.36.
CRSP −19.6% ADPT +53.5%Growth of $1, one year, split-adjusted
| Metric | CRSP | ADPT |
|---|---|---|
| Price | $51.42 | $26.64 |
| Market cap | $4.97B | $4.25B |
| Today | −5.23% | −5.43% |
| 1 month | −7.3% | −2.7% |
| 6 months | −0.4% | +86.7% |
| Year to date | −1.9% | +64.0% |
| 1 year | −17.8% | +58.6% |
| Revenue growth (YoY) | +1041.4% | +21.5% |
| Gross margin | 100.0% | 71.8% |
| Net margin | −895.3% | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | 371.3× | 13.8× |
| Net cash | $1.78B | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 53.4% | 50.5% |
| Short % of float | 21.0% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).